Jubilant Cadista Pharmaceuticals is recalling approximately 89,376 bottles of Pantoprazole Sodium (generic Protonix) Delayed-Release Tablets, 40 mg, sold in 90-count bottles. The recall was initiated because dark brown discoloration was found on the edges of the tablets, which indicates a deviation from manufacturing quality standards. Consumers should check their prescription bottles for specific lot numbers and consult their healthcare provider or pharmacist before making changes to their medication routine.
The dark brown discoloration on the tablet edges suggests potential chemical degradation or manufacturing defects. Using compromised medication may result in reduced effectiveness or exposure to unknown impurities, posing a moderate risk to patient health.
Guidance and refund for discolored tablets.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.